These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22795698)

  • 1. How dopamine enhances an optimism bias in humans.
    Sharot T; Guitart-Masip M; Korn CW; Chowdhury R; Dolan RJ
    Curr Biol; 2012 Aug; 22(16):1477-81. PubMed ID: 22795698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute dopaminergic and serotonergic manipulations in the ACI paradigm depend on the basal valence of cognitive judgement bias in rats.
    Golebiowska J; Rygula R
    Behav Brain Res; 2017 Jun; 327():133-143. PubMed ID: 28212943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making.
    Crockett MJ; Siegel JZ; Kurth-Nelson Z; Ousdal OT; Story G; Frieband C; Grosse-Rueskamp JM; Dayan P; Dolan RJ
    Curr Biol; 2015 Jul; 25(14):1852-9. PubMed ID: 26144968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine enhances expectation of pleasure in humans.
    Sharot T; Shiner T; Brown AC; Fan J; Dolan RJ
    Curr Biol; 2009 Dec; 19(24):2077-80. PubMed ID: 19913423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.
    Miguelez C; Navailles S; Delaville C; Marquis L; Lagière M; Benazzouz A; Ugedo L; De Deurwaerdère P
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1297-309. PubMed ID: 27234917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common drugs can affect moral decision making, study finds.
    Wise J
    BMJ; 2015 Jul; 351():h3605. PubMed ID: 26140927
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine induces an optimism bias in rats-Pharmacological proof for the translational validity of the ambiguous-cue interpretation test.
    Kregiel J; Golebiowska J; Popik P; Rygula R
    Behav Brain Res; 2016 Jan; 297():84-90. PubMed ID: 26462571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential, but not opponent, effects of L -DOPA and citalopram on action learning with reward and punishment.
    Guitart-Masip M; Economides M; Huys QJ; Frank MJ; Chowdhury R; Duzel E; Dayan P; Dolan RJ
    Psychopharmacology (Berl); 2014 Mar; 231(5):955-66. PubMed ID: 24232442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.
    Kannari K; Shen H; Arai A; Tomiyama M; Baba M
    Neurosci Lett; 2006 Jul; 402(1-2):62-5. PubMed ID: 16626862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum.
    Lopez A; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Neuroscience; 2001; 103(3):639-51. PubMed ID: 11274784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action controls dopaminergic enhancement of reward representations.
    Guitart-Masip M; Chowdhury R; Sharot T; Dayan P; Duzel E; Dolan RJ
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7511-6. PubMed ID: 22529363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
    Navailles S; Bioulac B; Gross C; De Deurwaerdère P
    Neurobiol Dis; 2010 Apr; 38(1):136-43. PubMed ID: 20096781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social Behavior: A Penny for Your Shocks.
    Dorfman HM; Buckholtz JW
    Curr Biol; 2015 Jul; 25(14):R600-1. PubMed ID: 26196484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa.
    Rampello L; Chiechio S; Raffaele R; Vecchio I; Nicoletti F
    Clin Neuropharmacol; 2002; 25(1):21-4. PubMed ID: 11852292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local administration of L-DOPA in the chicken ventromedial hypothalamus increases dopamine release in a dose-dependent manner.
    Alam MR; Yoshizawa F; Sugahara K
    Neurosci Lett; 2012 Nov; 529(2):150-4. PubMed ID: 22982146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic oral L-DOPA increases dopamine and decreases serotonin excretions.
    García NH; Berndt TJ; Tyce GM; Knox FG
    Am J Physiol; 1999 Nov; 277(5):R1476-80. PubMed ID: 10564221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex.
    Antinori S; Fattore L; Saba P; Fratta W; Gessa GL; Devoto P
    Addict Biol; 2018 Mar; 23(2):556-568. PubMed ID: 28429835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How unrealistic optimism is maintained in the face of reality.
    Sharot T; Korn CW; Dolan RJ
    Nat Neurosci; 2011 Oct; 14(11):1475-9. PubMed ID: 21983684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.
    Bishop C; George JA; Buchta W; Goldenberg AA; Mohamed M; Dickinson SO; Eissa S; Eskow Jaunarajs KL
    Eur J Neurosci; 2012 Sep; 36(6):2839-48. PubMed ID: 22762478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.